BioSyent Inc.
RX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.06% | -3.46% | 4.60% | 50.98% | 20.67% |
| Total Depreciation and Amortization | 1,153.13% | -10.13% | 10.03% | -1.23% | -136.53% |
| Total Amortization of Deferred Charges | -99.42% | 177.78% | -28.57% | -- | 352.24% |
| Total Other Non-Cash Items | 175.38% | -82.04% | 39.02% | -247.61% | -372.07% |
| Change in Net Operating Assets | 189.07% | 36,384.88% | -291.17% | 71.99% | -157.77% |
| Cash from Operations | 276.92% | 169.58% | -148.29% | 187.29% | -68.82% |
| Capital Expenditure | 25.08% | 26.53% | -106.90% | -- | -187.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 299.91% | -413.44% | 284.27% | -69.66% | 43.01% |
| Cash from Investing | 193.62% | -407.59% | 284.61% | -69.99% | 38.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.43% | -5.50% | -5.31% | -4.90% | -5.24% |
| Issuance of Common Stock | 142.45% | -- | -- | -- | -- |
| Repurchase of Common Stock | -361.21% | 96.23% | 75.17% | -101.41% | -75.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.53% | -8.42% | -5.78% | -8.64% | 2.61% |
| Other Financing Activities | 14.63% | 14.12% | 13.29% | 11.86% | 12.30% |
| Cash from Financing | -217.05% | 52.06% | 55.88% | -63.35% | -26.78% |
| Foreign Exchange rate Adjustments | 119.95% | -134.68% | -98.15% | -99.55% | -4,372.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.38% | 163.10% | 61.43% | 36.09% | -394.64% |